Literature DB >> 28994030

GeLC-MS: A Sample Preparation Method for Proteomics Analysis of Minimal Amount of Tissue.

Manousos Makridakis1, Antonia Vlahou2.   

Abstract

Application of various proteomics methodologies have been implemented for the global and targeted proteome analysis of many different types of biological samples such as tissue, urine, plasma, serum, blood, and cell lines. Among the aforementioned biological samples, tissue has an exceptional role into clinical research and practice. Disease initiation and progression is usually located at the tissue level of different organs, making the analysis of this material very important for the understanding of the disease pathophysiology. Despite the significant advances in the mass spectrometry instrumentation, tissue proteomics still faces several challenges mainly due to increased sample complexity and heterogeneity. However, the most prominent challenge is attributed to the invasive procedure of tissue sampling which restricts the availability of fresh frozen tissue to minimal amounts and limited number of samples. Application of GeLC-MS sample preparation protocol for tissue proteomics analysis can greatly facilitate making up for these difficulties. In this chapter, a step by step guide for the proteomics analysis of minute amounts of tissue samples using the GeLC-MS sample preparation protocol, as applied by our group in the analysis of multiple different types of tissues (vessels, kidney, bladder, prostate, heart) is provided.

Keywords:  GeLC-MS; Proteomics analysis; Sample preparation; Tissue proteomics

Mesh:

Substances:

Year:  2018        PMID: 28994030     DOI: 10.1007/7651_2017_76

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment.

Authors:  Joost P Schanstra; Trang Td Luong; Manousos Makridakis; Sophie Van Linthout; Vasiliki Lygirou; Agnieszka Latosinska; Ioana Alesutan; Beate Boehme; Nadeshda Schelski; Dirk Von Lewinski; William Mullen; Stuart Nicklin; Christian Delles; Guylène Feuillet; Colette Denis; Florian Lang; Burkert Pieske; Jean-Loup Bascands; Harald Mischak; Jean-Sebastien Saulnier-Blache; Jakob Voelkl; Antonia Vlahou; Julie Klein
Journal:  JCI Insight       Date:  2019-05-16

2.  An intrinsic role of IL-33 in Treg cell-mediated tumor immunoevasion.

Authors:  Aikaterini Hatzioannou; Aggelos Banos; Theodore Sakelaropoulos; Constantinos Fedonidis; Maria-Sophia Vidali; Maren Köhne; Kristian Händler; Louis Boon; Ana Henriques; Vasiliki Koliaraki; Panagiotis Georgiadis; Jerome Zoidakis; Aikaterini Termentzi; Marc Beyer; Triantafyllos Chavakis; Dimitrios Boumpas; Aristotelis Tsirigos; Panayotis Verginis
Journal:  Nat Immunol       Date:  2019-12-16       Impact factor: 25.606

3.  Targeted proteomic analysis dataset of archival core human kidney biopsies to investigate the biology of hypertensive nephropathy.

Authors:  Georgios Barkas; Manousos Makridakis; Hariklia Gakiopoulou; Demetrios Vlahakos
Journal:  Data Brief       Date:  2022-01-06

4.  Proteomic Analysis of Mouse Kidney Tissue Associates Peroxisomal Dysfunction with Early Diabetic Kidney Disease.

Authors:  Aggeliki Tserga; Despoina Pouloudi; Jean Sébastien Saulnier-Blache; Rafael Stroggilos; Irene Theochari; Harikleia Gakiopoulou; Harald Mischak; Jerome Zoidakis; Joost Peter Schanstra; Antonia Vlahou; Manousos Makridakis
Journal:  Biomedicines       Date:  2022-01-20

5.  In Situ Peroxidase Labeling Followed by Mass-Spectrometry Reveals TIA1 Interactome.

Authors:  Olga Gourdomichali; Katerina Zonke; Fedon-Giasin Kattan; Manousos Makridakis; Georgia Kontostathi; Antonia Vlahou; Epaminondas Doxakis
Journal:  Biology (Basel)       Date:  2022-02-11

6.  The Implant Proteome-The Right Surgical Glue to Fix Titanium Implants In Situ.

Authors:  Marcus Jäger; Agnieszka Latosinska; Monika Herten; André Busch; Thomas Grupp; Andrea Sowislok
Journal:  J Funct Biomater       Date:  2022-04-15

7.  Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness.

Authors:  Vasiliki Lygirou; Konstantinos Fasoulakis; Rafael Stroggilos; Manousos Makridakis; Agnieszka Latosinska; Maria Frantzi; Ioannis Katafigiotis; Christos Alamanis; Konstantinos G Stravodimos; Constantinos A Constantinides; Antonia Vlahou; Jerome Zoidakis
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

Review 8.  Mass spectrometry-based tear proteomics for noninvasive biomarker discovery.

Authors:  Erika Ponzini; Carlo Santambrogio; Antonella De Palma; Pierluigi Mauri; Silvia Tavazzi; Rita Grandori
Journal:  Mass Spectrom Rev       Date:  2021-03-24       Impact factor: 9.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.